Intersect Ent Inc
Officers & Directors
1. Thomas A. West - President and Chief Executive Officer - Mr. West joined Intersect ENT in as President and Chief Executive Officer. Prior to Intersect ENT, from 2010 to 2018, Mr. West held various executive positions at Smith & Nephew, most recently serving as President of Global Operations and Executive Vice President. Prior to joining Smith & Nephew, Mr. West held various leadership positions at GE Healthcare, where he served in various divisions beginning in 1998.
2. Randel G. Owen - Executive Vice President and Chief Financial Officer - Mr. Owen has over 25 years of financial management experience in the healthcare industry. Prior to joining Intersect ENT, he served as Chief Financial Officer of Allergan Medical, during which time he oversaw the division's transition to its integration with AbbVie. Mr. Owen also served as Chief Financial Officer of Precision Biosciences and as Senior Vice President of Finance at Baxano Surgical.
3. Richard A. Buchholz, M.D. - Executive Vice President and Chief Medical Officer - Dr. Buchholz joined Intersect ENT in as Executive Vice President and Chief Medical Officer. Prior to joining Intersect ENT, he was Professor of Otolaryngology at the University of North Carolina School of Medicine and Director of the Department of Otolaryngology-Head and Neck Surgery at UNC Hospitals. Dr. Buchholz is a highly regarded expert in the field of otolaryngology, with over 25 years of experience in clinical practice and research.
Directors:
1. Nancy A. Leaming - Chairperson of the Board of Directors - Ms. Leaming has been a member of the board of directors since and served as the Chairperson of the Board of Directors since . She also served as Intersect ENT's interim Chief Executive Officer from to . Ms. Leaming is currently managing partner of Connecticut-based healthcare consultancy, Leaming Advisory Group. Prior to starting Leaming Advisory Group, she held various executive management positions at GE Healthcare, where she worked from 1981 to 1999.
2. Jeryl Hilleman - Director - Ms. Hilleman has been a member of the board of directors since . Ms. Hilleman previously served as the Vice President and General Manager of the Ethicon Biosurgery business within Johnson & Johnson. She has also held senior leadership positions at C.R. Bard, Inc. and Pfizer.
3. Susan J. Stimson - Director - Ms. Stimson has been a member of the board of directors since . Ms. Stimson currently serves as the Chief Financial Officer of Kiniksa Pharmaceuticals, a role she has held since 2018. Prior to that, she held senior leadership roles at Verastem, Inc., Sanofi Genzyme, and Bristol-Myers Squibb Company. Thomas A. West - President and Chief Executive Officer - Mr. West joined Intersect ENT in as President and Chief Executive Officer. Prior to Intersect ENT, from 2010 to 2018, Mr. West held various executive positions at Smith & Nephew, most recently serving as President of Global Operations and Executive Vice President. Prior to joining Smith & Nephew, Mr. West held various leadership positions at GE Healthcare, where he served in various divisions beginning in 1998.
2. Randel G. Owen - Executive Vice President and Chief Financial Officer - Mr. Owen has over 25 years of financial management experience in the healthcare industry. Prior to joining Intersect ENT, he served as Chief Financial Officer of Allergan Medical, during which time he oversaw the division's transition to its integration with AbbVie. Mr. Owen also served as Chief Financial Officer of Precision Biosciences and as Senior Vice President of Finance at Baxano Surgical.
3. Richard A. Buchholz, M.D. - Executive Vice President and Chief Medical Officer - Dr. Buchholz joined Intersect ENT in as Executive Vice President and Chief Medical Officer. Prior to joining Intersect ENT, he was Professor of Otolaryngology at the University of North Carolina School of Medicine and Director of the Department of Otolaryngology-Head and Neck Surgery at UNC Hospitals. Dr. Buchholz is a highly regarded expert in the field of otolaryngology, with over 25 years of experience in clinical practice and research.
Directors:
1. Nancy A. Leaming - Chairperson of the Board of Directors - Ms. Leaming has been a member of the board of directors since and served as the Chairperson of the Board of Directors since . She also served as Intersect ENT's interim Chief Executive Officer from to . Ms. Leaming is currently managing partner of Connecticut-based healthcare consultancy, Leaming Advisory Group. Prior to starting Leaming Advisory Group, she held various executive management positions at GE Healthcare, where she worked from 1981 to 1999.
2. Jeryl Hilleman - Director - Ms. Hilleman has been a member of the board of directors since . Ms. Hilleman previously served as the Vice President and General Manager of the Ethicon Biosurgery business within Johnson & Johnson. She has also held senior leadership positions at C.R. Bard, Inc. and Pfizer.
3. Susan J. Stimson - Director - Ms. Stimson has been a member of the board of directors since . Ms. Stimson currently serves as the Chief Financial Officer of Kiniksa Pharmaceuticals, a role she has held since 2018. Prior to that, she held senior leadership roles at Verastem, Inc., Sanofi Genzyme, and Bristol-Myers Squibb Company. Thomas A. West - President and Chief Executive Officer - Mr. West joined Intersect ENT in as President and Chief Executive Officer. Prior to Intersect ENT, from 2010 to 2018, Mr. West held various executive positions at Smith & Nephew, most recently serving as President of Global Operations and Executive Vice President. Prior to joining Smith & Nephew, Mr. West held various leadership positions at GE Healthcare, where he served in various divisions beginning in 1998.
2. Randel G. Owen - Executive Vice President and Chief Financial Officer - Mr. Owen has over 25 years of financial management experience in the healthcare industry. Prior to joining Intersect ENT, he served as Chief Financial Officer of Allergan Medical, during which time he oversaw the division's transition to its integration with AbbVie. Mr. Owen also served as Chief Financial Officer of Precision Biosciences and as Senior Vice President of Finance at Baxano Surgical.
3. Richard A. Buchholz, M.D. - Executive Vice President and Chief Medical Officer - Dr. Buchholz joined Intersect ENT in as Executive Vice President and Chief Medical Officer. Prior to joining Intersect ENT, he was Professor of Otolaryngology at the University of North Carolina School of Medicine and Director of the Department of Otolaryngology-Head and Neck Surgery at UNC Hospitals. Dr. Buchholz is a highly regarded expert in the field of otolaryngology, with over 25 years of experience in clinical practice and research.
Directors:
1. Nancy A. Leaming - Chairperson of the Board of Directors - Ms. Leaming has been a member of the board of directors since and served as the Chairperson of the Board of Directors since . She also served as Intersect ENT's interim Chief Executive Officer from to . Ms. Leaming is currently managing partner of Connecticut-based healthcare consultancy, Leaming Advisory Group. Prior to starting Leaming Advisory Group, she held various executive management positions at GE Healthcare, where she worked from 1981 to 1999.
2. Jeryl Hilleman - Director - Ms. Hilleman has been a member of the board of directors since . Ms. Hilleman previously served as the Vice President and General Manager of the Ethicon Biosurgery business within Johnson & Johnson. She has also held senior leadership positions at C.R. Bard, Inc. and Pfizer.
3. Susan J. Stimson - Director - Ms. Stimson has been a member of the board of directors since . Ms. Stimson currently serves as the Chief Financial Officer of Kiniksa Pharmaceuticals, a role she has held since 2018. Prior to that, she held senior leadership roles at Verastem, Inc., Sanofi Genzyme, and Bristol-Myers Squibb Company. Thomas A. West - President and Chief Executive Officer - Mr. West joined Intersect ENT in as President and Chief Executive Officer. Prior to Intersect ENT, from 2010 to 2018, Mr. West held various executive positions at Smith & Nephew, most recently serving as President of Global Operations and Executive Vice President. Prior to joining Smith & Nephew, Mr. West held various leadership positions at GE Healthcare, where he served in various divisions beginning in 1998.
2. Randel G. Owen - Executive Vice President and Chief Financial Officer - Mr. Owen has over 25 years of financial management experience in the healthcare industry. Prior to joining Intersect ENT, he served as Chief Financial Officer of Allergan Medical, during which time he oversaw the division's transition to its integration with AbbVie. Mr. Owen also served as Chief Financial Officer of Precision Biosciences and as Senior Vice President of Finance at Baxano Surgical.
3. Richard A. Buchholz, M.D. - Executive Vice President and Chief Medical Officer - Dr. Buchholz joined Intersect ENT in as Executive Vice President and Chief Medical Officer. Prior to joining Intersect ENT, he was Professor of Otolaryngology at the University of North Carolina School of Medicine and Director of the Department of Otolaryngology-Head and Neck Surgery at UNC Hospitals. Dr. Buchholz is a highly regarded expert in the field of otolaryngology, with over 25 years of experience in clinical practice and research.
Directors:
1. Nancy A. Leaming - Chairperson of the Board of Directors - Ms. Leaming has been a member of the board of directors since and served as the Chairperson of the Board of Directors since . She also served as Intersect ENT's interim Chief Executive Officer from to . Ms. Leaming is currently managing partner of Connecticut-based healthcare consultancy, Leaming Advisory Group. Prior to starting Leaming Advisory Group, she held various executive management positions at GE Healthcare, where she worked from 1981 to 1999.
2. Jeryl Hilleman - Director - Ms. Hilleman has been a member of the board of directors since . Ms. Hilleman previously served as the Vice President and General Manager of the Ethicon Biosurgery business within Johnson & Johnson. She has also held senior leadership positions at C.R. Bard, Inc. and Pfizer.
3. Susan J. Stimson - Director - Ms. Stimson has been a member of the board of directors since . Ms. Stimson currently serves as the Chief Financial Officer of Kiniksa Pharmaceuticals, a role she has held since 2018. Prior to that, she held senior leadership roles at Verastem, Inc., Sanofi Genzyme, and Bristol-Myers Squibb Company.
The information provided is as of Intersect Ent Inc
Intersect Ent Inc currently has 420 employees.
|
|
